Objective measurement of therapeutic response in breast cancer using tumour markers.

[1]  J. M. Morrison,et al.  Steroid receptors in early breast cancer. , 1992, BMJ.

[2]  M. Williams,et al.  An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. , 1990, British Journal of Cancer.

[3]  M. Williams,et al.  Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy. , 1989, European journal of cancer & clinical oncology.

[4]  A. Howell,et al.  The definition of the 'no change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast. , 1988, European journal of cancer & clinical oncology.

[5]  O. Kallioniemi,et al.  Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer. , 1988, British Journal of Cancer.

[6]  J. Tjandra,et al.  Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA. , 1988, British Journal of Cancer.

[7]  J. Koda,et al.  Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker. , 1987, Cancer research.

[8]  D. Pons-Anicet,et al.  Value of CA 15:3 in the follow-up of breast cancer patients. , 1987, British Journal of Cancer.

[9]  P. Bruning,et al.  Comparison of circulating mam‐6 and cea levels and correlation with the estrogen receptor in patients with breast cancer , 1987, International journal of cancer.

[10]  H. Egami,et al.  Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen. , 1986, Japanese journal of clinical oncology.

[11]  M. Williams,et al.  Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers. , 1986, Cancer research.

[12]  John S. Silva,et al.  Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen , 1982, Cancer.

[13]  W. Bezwoda,et al.  Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer , 1981, Cancer.

[14]  T. Powles,et al.  Screening for metastases in breast cancer: An assessment of biochemical and physical methods , 1981, Cancer.

[15]  A. van Dalen,et al.  Tumour markers in breast cancer. , 1979, British medical journal.

[16]  S. Wells,et al.  Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma , 1978, Cancer.

[17]  F. Smiddy,et al.  Multivariate biochemical indicators of breast cancer: an evaluation of their potential in routine practice. , 1978, European journal of cancer.

[18]  K. Woo,et al.  Biologic markers in breast carcinoma. IV. Serum fucose‐protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin , 1978, Cancer.

[19]  K. Woo,et al.  A quantitative approach to determining disease response during therapy using multiple biologic markers. Application to carcinoma of the breast , 1978, Cancer.

[20]  T. Powles,et al.  A biochemical approach to the staging of human breast cancer , 1977, Cancer.

[21]  P. Franchimont,et al.  Simultaneous assays of cancer‐associated antigens in various neoplastic disorders , 1976, Cancer.

[22]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[23]  G. Beatson.  On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases , 1896, Transactions. Medico-Chirurgical Society of Edinburgh.

[24]  A. Howell,et al.  Assessment of four monoclonal antibodies as serum markers in breast cancer. , 1990, European journal of cancer.

[25]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.

[26]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland. , 1978, European journal of cancer.

[27]  Britishbreastgroup.  ASSESSMENT OF RESPONSE TO TREATMENT IN ADVANCED BREAST CANCER , 1974 .